Delivery Order HHSA290201200011I-HHSA29032001T

The Defense Health Agency awarded a $23,697.13 firm fixed-price call order to Harvard Bioscience Inc. (operating as Data Sciences International) on December 5, 2024, for medical research implants, with performance scheduled to conclude by September 30, 2025. This contract call is issued under Harvard Bioscience's existing $4.8 million single-award Blanket Purchase Agreement with the Defense Health Agency, which was established on May 4, 2022, and remains active through May 3, 2027. The BPA...

Rivanna Medical, Inc. has been awarded a $91.5 million cost-plus-fixed-fee definitive contract by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the Department of Health and Human Services to develop, refine, and manufacture the Accuro XV, a handheld ultrasound device designed for rapid, radiation-free fracture triage in mass casualty blast trauma incidents. The contract, which is not set-aside and has an ultimate completion date of September 29, 2029,...

This delivery order task (H-126361) was awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., by the National Cancer Institute on September 27, 2023, for the Wedgewood Suite M & N Expansion modification project in Frederick, Maryland. The contract carries a ceiling value of $16.4 million and extends through June 18, 2026, utilizing a cost-plus-fixed-fee pricing structure with no set-aside designation. Leidos Biomedical Research Inc. operates as a Federally Funded...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $5.46 million definitive contract to La Jolla Institute for Immunology to identify and validate epitopes conserved across viral pathogen families with pandemic potential. The contract, awarded September 30, 2024, with completion by September 29, 2029, supports NIAID's mission to advance understanding of infectious diseases and vaccine development through discovery of T cell immune epitopes. This non-set-aside,...

The Defense Health Agency awarded a $12.39 million firm fixed-price purchase order to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. on February 15, 2023, to conduct a casualty care assessment of the Russo-Ukraine War. The contract, which has no set-aside designation and extends through September 29, 2025, will be performed in Frederick, Maryland. This work directly supports Section 736 of the Fiscal Year 2021 National Defense Authorization Act, which directed the...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $24.3 million definitive contract to La Jolla Institute for Immunology on March 15, 2026, for continued support and enhancement of the Immune Epitope Database and Analysis Resource (IEDB). The contract, which extends through December 2030, supports NIAID's mission to maintain and expand this central research resource that provides the scientific community with searchable experimental data on antibody and T-cell...

The Defense Health Agency awarded a $49.0M definitive cost-plus-fixed-fee contract to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. on August 29, 2021, to provide non-personal support services for infectious disease surveillance across Kenya, Uganda, Tanzania, and sub-Saharan Africa. The work directly supports the Walter Reed Army Institute of Research (WRAIR) Medical Research Detachment in Africa, which operates under the Department of Defense's Global...

The National Cancer Institute awarded a $17.5 million delivery order to the Illinois Department of Public Health (IDPH) on March 3, 2021, for core infrastructure support of the Surveillance Epidemiology and End Results (SEER) Program. This delivery order was issued under a larger $500 million multiple-award indefinite delivery vehicle (IDV) administered by the National Cancer Institute through April 30, 2028. The contract utilizes cost-sharing pricing and carries no set-aside designation,...

The National Institute of Allergy and Infectious Diseases awarded a $131.6 million definitive contract to The Trustees of the University of Pennsylvania for the Centers of Excellence for Influenza Research and Response (CEIRR) on April 1, 2021, under a cost-reimbursement, no-fee pricing structure. The contract supports a multi-disciplinary collaborative research network focused on influenza natural history, transmission, pathogenesis, prevention, and control measures. Penn-CEIRR integrates basic...

The National Heart Lung and Blood Institute (NHLBI) awarded a definitive cost-plus-no-fee contract to Fred Hutchinson Cancer Research Center for the Women's Health Initiative (WHI) Clinical Coordinating Center, effective April 1, 2016, with a ceiling value of approximately $60.3 million and an ultimate completion date of January 31, 2021. This non-set-aside contract is performed in Seattle, Washington, and represents the NHLBI's continued investment in the WHI, a landmark longitudinal study...